Nucleome is backed by a world-class syndicate of investors: M Ventures, the venture capital arm of Merck KGaA; Johnson and Johnson Innovation - JJDC, Inc. ("JJDC"); Pfizer Ventures; British Business ...

Priority Research Communication by Professor Yogesh Dwivedi and colleagues at the University of Alabama at Birmingham reports original, peer-reviewed findings demonstrating that long noncoding RNAs ...

Solid Oxide Fuel Cells (SOFCs) are a new type of fuel cell that directly converts chemical energy into electrical energy and have attracted widespread ...

Researchers at Northwestern University have developed a new class of drugs, using spherical nucleic acid, to deliver ...

In his later years, Watson's reputation was tarnished by comments on genetics and race that led him to be ostracized by the ...

James D. Watson, the brilliant but controversial American biologist whose 1953 discovery of the structure of DNA, the ...

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that members of Recludix’s ...

Oxford University and Austrian researchers uncover a previously unknown ‘handbrake’ mechanism controlling how cells respond to cancer drugs, reshaping global understanding of cell metabolism and drug ...

Convertible issuance was exceptionally robust over the quarter, and we expect a favorable issuance environment to continue.